Kymera Therapeutics, Inc. (KYMR)
122.86
+1.81
(+1.50%)
USD |
NASDAQ |
Aug 25, 09:57
Kymera Therapeutics 1 Year Total Returns (Daily) : 174.5% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 174.5% |
| August 21, 2026 | 181.3% |
| August 20, 2026 | 186.9% |
| August 19, 2026 | 199.1% |
| August 18, 2026 | 178.3% |
| August 17, 2026 | 184.8% |
| August 14, 2026 | 182.5% |
| August 13, 2026 | 180.9% |
| August 12, 2026 | 186.0% |
| August 11, 2026 | 190.9% |
| August 10, 2026 | 167.3% |
| August 07, 2026 | 163.2% |
| August 06, 2026 | 157.3% |
| August 05, 2026 | 145.5% |
| August 04, 2026 | 139.1% |
| August 03, 2026 | 133.5% |
| July 31, 2026 | 136.3% |
| July 30, 2026 | 142.8% |
| July 29, 2026 | 140.8% |
| July 28, 2026 | 140.2% |
| July 27, 2026 | 140.3% |
| July 24, 2026 | 141.2% |
| July 23, 2026 | 137.7% |
| July 22, 2026 | 141.1% |
| July 21, 2026 | 151.2% |
| Date | Value |
|---|---|
| July 20, 2026 | 140.5% |
| July 17, 2026 | 149.8% |
| July 16, 2026 | 150.5% |
| July 15, 2026 | 154.1% |
| July 14, 2026 | 149.6% |
| July 13, 2026 | 148.2% |
| July 10, 2026 | 164.0% |
| July 09, 2026 | 163.4% |
| July 08, 2026 | 162.9% |
| July 07, 2026 | 172.2% |
| July 06, 2026 | 156.2% |
| July 02, 2026 | 154.9% |
| July 01, 2026 | 157.0% |
| June 30, 2026 | 162.8% |
| June 29, 2026 | 147.8% |
| June 26, 2026 | 136.5% |
| June 25, 2026 | 150.6% |
| June 24, 2026 | 111.9% |
| June 23, 2026 | 112.2% |
| June 22, 2026 | 116.8% |
| June 18, 2026 | 94.72% |
| June 17, 2026 | 93.96% |
| June 16, 2026 | 86.68% |
| June 15, 2026 | 82.26% |
| June 12, 2026 | 82.29% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 306.6% |
| Oncolytics Biotech, Inc. | -16.43% |
| Sangamo Therapeutics, Inc. | -72.71% |
| Sarepta Therapeutics, Inc. | -10.34% |
| Anixa Biosciences, Inc. | 18.30% |